Antibiotic Selection for Purulent Skin and Soft-Tissue Infections in Ambulatory Care: A Decision-Analytic Approach

Academic Pediatrics

Volumn 9, Issue 3, 2009, Pages 179-184

  Hersh, Adam L ^a   Weintrub, Peggy S ^a   Cabana, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

decision analysis; methicillin resistant Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CLINDAMYCIN; COTRIMOXAZOLE; METICILLIN;

AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DECISION MAKING; DRUG PREFERENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; SENSITIVITY ANALYSIS; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS GROUP A;

AMBULATORY CARE; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CEPHALEXIN; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DECISION SUPPORT TECHNIQUES; DRUG RESISTANCE; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MULTIVARIATE ANALYSIS; PROBABILITY; SENSITIVITY AND SPECIFICITY; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 65449144590     PISSN: 18762859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acap.2009.02.002     Document Type: Article

References (21)

1. Hersh A.L., Chambers H.F., Maselli J.H., and Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 168 (2008) 1585-1591
2. Moran G.J., Krishnadasan A., Gorwitz R.J., et al., EMERGEncy ID Net Study Group. Methicillin-resistant S aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
3. Stevens D.L., Bisno A.L., Chambers H.F., et al. Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41 (2005) 1373-1406
4. Zaoutis T.E., Toltzis P., Chu J., et al. Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatr Infect Dis J 25 (2006) 343-348
5. Hultén K.G., Kaplan S.L., Gonzalez B.E., et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J 25 (2006) 349-353
6. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and Participants in the CDC-Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. March 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdf. Accessed February 19, 2009.
7. Baker C.J. Large CA-MRSA disease burden mandates prompt diagnosis, appropriate management. AAP News 28 (2007) 1 9
8. Kaplan S.L. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 24 (2005) 457-458
9. Liu C., Graber C.J., Karr M., et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis 46 (2008) 1637-1646
10. Daum R.S. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 357 (2007) 380-390
11. Phillips S., MacDougall C., and Holdford D.A. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus. Ann Pharmacother 41 (2007) 13-20
12. Daneman N., Low D.E., McGeer A., et al. At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia. Clin Infect Dis 46 (2008) 1131-1138
13. Le T.P., and Miller L.G. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Clin Infect Dis 33 (2001) 615-621
14. Evans R.S., Classen D.C., Pestotnik S.L., et al. Improving empiric antibiotic selection using computer decision support. Arch Intern Med 154 (1994) 878-884
15. Evans R.S., Pestotnik S.L., Classen D.C., et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 338 (1998) 232-238
16. Beardsley J.R., Williamson J.C., Johnson J.W., et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 130 (2006) 787-793
17. Hersh A.L., Cabana M.D., Gonzales R., Shenkin B.N., and Cho C.S. Pediatricians' perspectives on the impact of MRSA in primary care: a qualitative study. BMC Pediatr (2009) in press
18. Ellingson K.D., Gorwitz R., and Pearson M.L. Variability in Practice Patterns for Outpatient Management of Staphylococcal Skin and Soft Tissue Infections-2005 (2007), Infectious Diseases Society of America, San Diego, Calif
19. McCaig L.F., McDonald L.C., Mandal S., and Jernigan D.B. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis 12 (2006) 1715-1723
20. Ruhe J.J., Smith N., Bradsher R.W., and Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 44 (2007) 777-784
21. Chuck EA, Frazee BW, Lambert L, McCabe R. The benefit of empiric treatment for methicillin-resistant Staphylococcus aureus. J Emerg Med. In press.